Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05722418
Status:
RECRUITING
Last Update Posted:
2024-05-06
First Post:
2022-12-19
Brief Title:
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With RelapsedRefractory Multiple Myeloma
Sponsor:
Caribou Biosciences Inc
Organization:
Caribou Biosciences Inc
Organization Data
Organization:
Caribou Biosciences Inc
Class:
INDUSTRY
Study ID:
CB11A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Caribou Biosciences Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None